Advaxis, Inc. (ADXS) financial statements (2020 and earlier)

Company profile

Business Address 305 COLLEGE ROAD EAST
PRINCETON,, NJ 08540
State of Incorp. DE
Fiscal Year End October 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
10/31/2014
10/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3244711521121821
Cash and cash equivalents324424113671821
Short-term investments   3946  
Other undisclosed cash, cash equivalents, and short-term investments  47    
Restricted cash and investments 1     
Receivables  4322 
Prepaid expense   1000
Deferred costs2234110
Other current assets   0000
Other undisclosed current assets133    
Total current assets:3650811601152021
Noncurrent Assets
Property, plant and equipment4774100
Intangible assets, net (including goodwill)5554333
Intangible assets, net (excluding goodwill)5554333
Other noncurrent assets00000  
Other undisclosed noncurrent assets     00
Total noncurrent assets:912129533
TOTAL ASSETS:4562941691202324
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4121413445
Accounts payable1652114
Accrued liabilities36911311
Employee-related liabilities     11
Debt      0
Deferred revenue and credits715   
Other liabilities000    
Other undisclosed current liabilities011 00(1)(1)
Total current liabilities:5232128435
Noncurrent Liabilities
Liabilities, other than long-term debt111 001
Other liabilities111    
Derivative instruments and hedges, liabilities    001
Other undisclosed noncurrent liabilities 141722   
Total noncurrent liabilities:1151922001
Total liabilities:6383950436
Stockholders' equity
Stockholders' equity attributable to parent, including:4024541191162118
Common stock0000000
Treasury stock, value   (0)(0)  
Additional paid in capital42439235532725010888
Accumulated deficit(384)(368)(301)(208)(134)(87) 
Other undisclosed stockholders' equity attributable to parent      (70)
Total stockholders' equity:4024541191162118
TOTAL LIABILITIES AND EQUITY:4562941691202324

Income statement (P&L) ($ in millions)

10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
10/31/2014
10/31/2013
Revenue, net124 1 
Gross profit:216124 1 
Operating expenses(39)(76)(111)(80)(49)(21)(15)
Operating loss:(18)(70)(99)(76)(49)(20)(15)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)(0)(0)(0)(0)0(0)
Interest and debt expense     0(4)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes141001(2)
Loss from continuing operations before income taxes:(17)(66)(98)(76)(49)(19)(21)
Income tax expense (benefit)(0)(0)43221
Net loss attributable to parent:(17)(67)(93)(74)(47)(17)(20)
Preferred stock dividends and other adjustments      (1)
Net loss available to common stockholders, diluted:(17)(67)(93)(74)(47)(17)(21)

Comprehensive Income ($ in millions)

10/31/2019
10/31/2018
10/31/2017
10/31/2016
10/31/2015
10/31/2014
10/31/2013
Net loss:(17)(67)(93)(74)(47)(17)(20)
Comprehensive loss, net of tax, attributable to parent:(17)(67)(93)(74)(47)(17)(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: